14/10/2010 - 00:00

$650,000 for cancer research

14/10/2010 - 00:00

Bookmark

Save articles for future reference.

A COMPANY behind scientists undertaking cancer research will become the first Western Australian investment for the Medical Research Commercialisation Fund, receiving $650,000.The company, MiReven, is a start-up dedicated to commercialising a molecule known as microRNA, which has shown promise as an

This article is only available to our paid subscribers.

To read this article and get full access to every insight Business News offers, subscribe today.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options